Ein Serverraum (Symbolbild).
Quelle: © cybrain/ iStock / Getty Images Plus/ gettyimages.de www.gettyimages.de
Google
neu
Die Newsartikel wurden besser lesbar gestaltet.
Mehr erfahren
PR Newswire  | 

Lifshitz & Miller LLP Announces Investigation of Adesto Technologies Corporation, Delphi Technologies PLC, FGL Holdings, Forescout Technologies, Inc., Franklin Financial Network, Inc., Neon Therapeutics, Inc., Stein Mart, Inc., and Taubman Centers, Inc.

PR Newswire

Anhören
Teilen
Feedback
Kopieren
ARIVA Newsletter
Adesto Technologies -   Adesto Technologies Chart 0,00%
Delphi Technologies -   Delphi Technologies Chart 0,00%
FGL Holdings -   FGL Holdings Chart 0,00%
Forescout Technologies -   Forescout Technologies Chart 0,00%
Neon Therapeutics -   Neon Therapeutics Chart 0,00%
Stein Mart -   Stein Mart Chart 0,00%
Taubman Centers -   Taubman Centers Chart 0,00%

NEW YORK, Feb. 24, 2020 /PRNewswire/ -- 

Adesto Technologies Corporation (IOTS)

Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of Adesto to Dialog Semiconductor plc for $12.55 per share.

If you are an Adesto investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Delphi Technologies PLC (DLPH)

Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of Delphi to BorgWarner Inc. for 0.4534 shares of BorgWarner per share of Delphi owned.

If you are a Delphi investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

FGL Holdings (FG)

Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of FG to Fidelity National Financial, Inc. for $12.50 per share.

If you are an FGL Holdings investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Forescout Technologies, Inc. (FSCT)

Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of FSCT to Advent International for $33.00 per share.

If you are an FSCT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Franklin Financial Network, Inc. (FSB)

Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of FSB to FB Financial Corporation.

If you are a FSB investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Neon Therapeutics, Inc. (NTGN)

Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of NTGN to BioNTech SE.

If you are a NTGN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Stein Mart, Inc. (SMRT)

Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of SMRT to Kingswood Capital Management, L.P. for $0.90 per share.

If you are a SMRT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Taubman Centers, Inc. (TCO)

Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of Taubman to Simon Property Group, Inc. for $52.50 per share.

If you are a Taubman investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING.© 2020 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com

Cision View original content:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-adesto-technologies-corporation-delphi-technologies-plc-fgl-holdings-forescout-technologies-inc-franklin-financial-network-inc-neon-therapeutics-inc-stein-mart-inc-an-301010151.html

SOURCE Lifshitz & Miller LLP


Community-Beiträge zu Neon Therapeutics

aus Forum-Thread: NTGN 2,66$
Avatar des Verfassers
07.05.2020 - 16:16 Uhr
Vassago
NTGN 3.07$
Übernahme abgeschlossen "As of May 7, 2020, Neon’s common stock will no longer be available for trading." https://investors.biontech.de/news-releases/news-release-details/biontech-completes-acquisition-neon-therapeutics
Avatar des Verfassers
05.05.2020 - 13:53 Uhr
iTechDachs
Pfizer und BioNTech melden erste US-Patienten
Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development ProgramPfizer Inc. (PFE) and BioNTech SE (BNTX) announced today that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. This U.S. trial is ...
Jetzt anmelden und diskutieren Registrieren Login

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.